Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DiaCarta

DiaCarta
2010 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series B LATEST DEAL TYPE
$45M LATEST DEAL AMOUNT
3 INVESTORS
Description

Operator of translational genomics and personalized diagnostics company designed to provide highly sensitive and advanced technologies that will improve the way molecular diagnostics and translational genomics impact healthcare treatment plans. The company focuses on genomic innovation through detection and amplification technologies and develops a range of cancer research and IVD products, specialized in genomic testing for biomarkers and offers clinical sample testing services.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 2600 Hilltop Drive
  • Building B, 3rd Floor
  • Richmond, CA 94806
  • United States

+1 (800) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore DiaCarta’s full profile, request a free trial.

DiaCarta Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 12-Feb-2018 $45M 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 09-Jan-2015 000 000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

DiaCarta Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genomic Health Formerly VC-backed Redwood City, CA 000 00000 000000&0 00000
0000000 00000000 Venture Capital-Backed Milpitas, CA 00 000.00 00000000000 000.00
00000000 Private Equity-Backed Seattle, WA 0000 000000000 0000
000000000 Corporation San Diego, CA
00000000 000000000 Venture Capital-Backed Westlake Village, CA 00 000.00 0000000000 0 000.00
To view this company’s complete list of competitors, request access »

DiaCarta Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Fortune Fountain Capital PE/Buyout Minority 000 0000 000000 0
Global Healthcare Capital Real Estate Minority 000 0000 000000 0
BVCF Venture Capital Minority 000 0000 000000 0

DiaCarta Executive Team (5)

Name Title Board
Seat
Contact
Info
Aiguo Zhang Ph.D Co-Founder, President & Chief Executive Officer
Michael Powell Ph.D Chief Scientific Officer
Cynthia Virata Director of QA and Operations
Paul Okunieff MD Co-Founder, Medical Advisors & Chief Medical Officer

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

DiaCarta Board Members (1)

Name Representing Role Since Contact
Info
Weixin Xu Ph.D BVCF Board Member 000 0000